|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/48 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2854841 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13801165.5 |
| Date of filing the European patent application | 2013-06-04 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-22 |
| (46) | Date of publication of the claims translation | 2017-06-12 |
| (86) | Number | PCT/CA2013/050425 |
| Date | 2013-06-04 |
| (87) | Number | WO 2013/181755 |
| Date | 2013-12-12 |
| (30) | Number | Date | Country code |
| 201261655388 P | 2012-06-04 | US | |
| 201361789978 P | 2013-03-15 | US |
| (72) |
CHARLES, Matthew, US
KOLODKA, Tadeusz, US
WILLIAMS, Mark, US
|
| (73) |
DiaMedica Therapeutics Inc.,
301 - 1665 Ellis Street, Kelowna BC V1Y 2B3,
CA
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kalikreino 1 iš žmogaus audinio glikozilinimo izoformos |
| HUMAN TISSUE KALLIKREIN 1 GLYCOSYLATION ISOFORMS |
| Payment date | Validity (years) | Amount | |
| 2018-07-20 | 6 | 208.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-06-04 |